The consistency statement in causal inference: A definition or an assumption?

Epidemiology

Volumn 20, Issue 1, 2009, Pages 3-5

  Cole, Stephen R ^a   Frangakis, Constantine E ^b  

^a IL   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEDICAL EDUCATION; MEDICAL LITERATURE; MEDICAL RESEARCH; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

CAUSALITY; EPIDEMIOLOGIC STUDIES; PUBLISHING; TERMINOLOGY AS TOPIC;

EID: 67651098902     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e31818ef366     Document Type: Note

References (22)

1. Holland PW. Statistics and causal inference. JASA. 1986;81:945-970.
2. Hernán MA, Robins JM. Estimating causal effects from epidemiological data. J Epidemiol Community Health. 2006;60:578 -586.
3. Cole SR, Hernán MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008;168:656-664.
4. Robins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11:550 -560.
5. Hernán MA. Invited commentary: hypothetical interventions to define causal effects-afterthought or prerequisite? Am J Epidemiol. 2005;162: 618-620; discussion 21-22.
6. Hernán MA, Taubman SL. Does obesity shorten life? The importance of well-defined interventions to answer causal questions. Int J Obes. 2008;32(suppl 3):S8 -S14.
7. Rubin DB. Estimating causal effects of treatments in randomized and nonrandomized studies. J Educ Psychol. 1974;66:688 -701.
8. Hernán MA. A definition of causal effect for epidemiological research. J Epidemiol Community Health. 2004;58:265-271.
9. Robins J. A graphical approach to the identification and estimation of causal parameters in mortality studies with sustained exposure periods. J Chronic Dis. 1987;40:139S-161S.
10. Frangakis CE, Rubin DB. Principal stratification in causal inference. Biometrics. 2002;58:21-29.
11. Hernán MA, Brumback B, Robins JM. Marginal structural models to estimate the joint causal effect of non-randomized treatments. JASA. 2001;96:440-448.
12. Cole SR, Hernán MA, Anastos K, et al. Determining the effect of highly active antiretroviral therapy on changes in human immunodeficiency virus type 1 RNA viral load using a marginal structural left-censored mean model. Am J Epidemiol. 2007;166:219 -227.
13. Dawid AP. Causal inference without conterfactuals. JASA. 2000;95: 407-424.
14. Greenland S, Robins JM. Identifiability, exchangeability, and epidemiological confounding. Int J Epedemiol. 1986;15:413-418.
15. Greenland S, Poole C. Invariants and noninvariants in the concept of interdependent effects. Scand J Work Environ Health. 1988;14:125-129.
16. Robins JM, Greenland S. Identifiability and exchangeability for direct and indirect effects. Epidemiology. 1992;3:143-155.
17. Frangakis CE, Brookmeyer R, Varadhan R, et al. Methodology for evaluating a partially controlled longitudinal treatment using principal stratification, with application to a needle exchange program. JASA. 2004;99:239 -249.
18. Rubin DB. Statistics and Causal Inference: Comment: Which Ifs Have Causal Answers. JASA. 1986;81:961-962.
19. van der Laan M, Haight T, Tager IB. Response to "Hypothetical interventions to define causal effects." Am J Epidemiol. 2005;162:621-622.
20. Steg PG, Bonnefoy E, Chabaud S, et al. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation. 2003;108:2851-2856.
21. Robins JM, Greenland S. Comment on: causal inference without counterfactuals. JASA. 2000;95:431-435.
22. Prentice RL, Langer R, Stefanick ML, et al. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial. Am J Epidemiol. 2005;162:404-414.